International Congress of Immunology - Travel Awards

描述（由申请人提供）：本资助申请为研究生、博士后和初级教师提供200个旅行奖，每个1000美元，共计20万美元，用于参加由IUIS（国际免疫学学会联合会）和FOCIS（临床免疫学学会联合会）主办的第12届国际免疫学大会（ICI），该会议将于2004年7月18日至23日在加拿大魁北克省蒙特利尔举行。本申请申请的资金约占旅游奖预算的40%。额外的资金要么已经获得，要么正在向机构、慈善机构和工业赞助商申请。ICI科学计划包括专题讨论会，海报会议和研讨会，分为5个主题：免疫调节，宿主抗性，免疫遗传学，免疫诊断和免疫干预。大会将通过10个主题演讲，5个未来挑战会议，35个专题讨论会，150个互动研讨会（迷你研讨会）和10个海报会议（每个会议有大约500个摘要）提供有关免疫学研究基础和应用进展的最新信息。该项目还包括有关免疫学的公共信息、免疫学研究发现从实验室到临床再到社区的转移、免疫学技术从大学到工业的转移以及社会和伦理问题等主题。一些创新将使ICI成为一个有效的传播论坛，包括：有效的摘要提交和检索，保证免疫学研究进展的最新报道，以任务为导向的会议，使用数字多功能光盘技术创建海报超媒体图书馆，以及促进大学和行业之间有效互动的结构化机会。ICI与FOCIS年度会议的整合将促进基础研究转化为免疫介导炎性疾病的新诊断、预防和治疗方法。学员和新的研究人员将有充分的机会了解免疫学基础科学的突破在哪里以及如何进入临床。预计大会出席人数为10,000人，其中70%来自美国，其余来自加拿大、欧洲、南美、亚洲和非洲。我们估计50%的与会者将是年轻的研究人员。已确认的演讲者和专题讨论会/小型专题讨论会主席来自20个国家，其中53%来自美国。我们的国会教职员工中有20%是女性，10%要么是少数族裔成员，要么来自美国和加拿大的少数族裔。

DESCRIPTION (provided by applicant): This grant request is for two hundred (200) Travel Awards of $1,000 each for a total of $200,000, for graduate students, post-doctoral fellows and junior faculty members to attend the 12th International Congress of Immunology (ICI) to be held July 18-23, 2004 in Montreal, Quebec, Canada under the auspices of IUIS (International Union of Immunology Societies) and FOCIS (Federation of Clinical Immunology Societies). This application request funds for approximately 40% of the Travel Award budget. Additional funding is either already secured or is being requested from institutional, charitable and industrial sponsors. The ICI scientific program consists of symposia, poster sessions and workshops subdivided into 5 themes: Immune Regulation, Host Resistance, Immunogenetics, Immunodiagnosis and Immunointervention. The Congress will provide the most up-to-date information on the basic and applied advances in immunology research through the mix of 10 Keynote Lectures, 5 Future Challenges sessions, 35 Symposia, 150 Interactive Workshops (Minisymposia) and 10 Poster Sessions (each with approximately 500 abstracts). The program also includes topics such as public information about immunology, transfer of research discoveries in immunology from the bench to bedside to community, technology transfer in immunology from university to industry and social and ethical issues. Several innovations will make the ICI an effective forum for dissemination, including: effective abstract submission and retrieval, assurance of up-to-date coverage of advances in immunology research, mission-oriented sessions, creation of a hyper-media library of posters using a digital versatile disc technology, and structured opportunities to facilitate effective interaction between university and industry. The integration of the ICI with the annual FOCIS conference will promote translation of fundamental research to new diagnostic, preventive and therapeutic approaches to immune-mediated inflammatory disorders. Trainees and new investigators will be offered ample opportunity to understand where and how breakthroughs in basic science of immunology are coming into the clinic. The expected Congress attendance is 10,000 participants, 70% from the USA and the remainder from Canada, Europe, South America, Asia and Africa. We estimate that 50% of our attendees will be young investigators. The confirmed speakers and symposia/minisymposia chairs come from 20 countries, 53% being from the USA. Twenty % of our Congress Faculty are women and 10% are either members of visible minorities or come from the homelands of US and Canadian minorities.